Patent directory · USPTO A61K / A61P
Patents matching “CAN-FITE BIOPHARMA LTD.”
23 pharma patents match "CAN-FITE BIOPHARMA LTD." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 23 pharmaceutical patents matching "CAN-FITE BIOPHARMA LTD." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12213990
A3 adenosine receptor ligand for use for achieving a fat loss effect
granted -
US 11291681
Method for treating fibrotic liver tissue using Cl-IB-MECA
granted -
US 10780106
Method for treating NASH accompanied by fibrosis using Cl-IB-MECA
granted -
US 10265337
Use of A3 adenosine receptor agonist in osteoarthritis treatment
granted -
US 9549943
A3 adenosine receptor ligands for use in treatment of a sexual dysfunction
granted -
US 9387220
Method for inducing hepatocyte proliferation and uses thereof
granted -
US 9102698
Process for the synthesis of IB-MECA
granted -
US 8987228
Pharmaceutical composition including an A3 adenosine receptor agonist 1-deooxy-1-[N6-(3-idobenzyl)-adenin-9-yl]-N-methyl-β-D-ribofuronamide(IB-MECA/CF-101) for treatment of psoriasis
granted -
US 8846635
Method for inducing hepatocyte proliferation and uses thereof
granted -
US 8557790
A3 adenoside receptor agonists for the reduction of intraocular pressure
granted -
US 8541182
Biological marker for inflammation
granted -
US 7825102
Treatment of dry eye conditions
granted -
US 7589075
Use of an adenosine A3 receptor agonist for inhibition of viral replication
granted -
US 7465715
Method for treatment of multiple sclerosis
granted -
US 7189706
C2,5′-disubstituted and N6,C2,5′-trisubstituted adenosine derivatives and pharmaceutical compositions containing them
granted -
US 7141553
A3AR agonists for the treatment of inflammatory arthritis
granted -
US 7112574
C2,8-disubstituted adenosine derivatives and their different uses
granted -
US 7084127
C2,5′-disubstituted and N6, C2,5′-trisubstituted adenosine derivatives and their different uses
granted -
US 7064112
Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist
granted -
US 6911435
Method of treating leukopenia with adenosine
expired -
US 6790839
Pharmaceutical administration of adenosine agonists
expired -
US 6638914
Pharmaceutical administration of adenosine agonists
expired -
US 6537587
Compositions containing muscle-derived active agents
expired